Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality [Phase 3]
A Phase 3 trial comparing lenalidomide to placebo in myelodysplastic syndromes with a deletion 5q abnormality has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion [Phase 3]
A Phase 3 trial evaluating weekly epoetin alfa at two doses versus placebo in patients with low or intermediate-1 risk myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 study evaluating all-trans retinoic acid and bryostatin in patients with acute myeloid leukemia and myelodysplastic syndromes has co…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia [Phase 1]
Phase 1 clinical trial evaluating vaccination with autologous acute myeloid leukemia cells in adults with advanced myelodysplastic syndromes…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and umbilical cord blood transplantation in patients with hematologic can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
Completed Phase 2 study evaluating donor umbilical cord blood transplantation for patients with leukemia, lymphoma, and certain nonmalignant…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [Phase 2]
A Phase 2 clinical trial evaluating umbilical cord blood transplantation for hematologic cancers and related diseases has been completed.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure [Phase 2]
Phase 2 trial evaluating low-dose decitabine in myelodysplastic syndromes after azacitidine failure; the study was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating treosulfan with fludarabine as conditioning before donor stem cell transplant in younger patients with AML, ALL, …
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid [Phase 2]
Phase 2 safety and efficacy study of romiplostim (AMG 531) in patients with myelodysplastic syndromes receiving Revlimid. Results were poste…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial update reporting the determination of a safe dose of romiplostim (AMG 531) in patients with myelodysplastic syndromes, with re…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil [NA]
This clinical trial update reports termination of a study evaluating tacrolimus with mycophenolate mofetil for graft-versus-host disease pro…
-
CLINICAL_TRIALS trial_result · 2010-10-14Clinical Trial Update: Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders [NA]
This clinical trial update documents the status of a non-myeloablative allogeneic transplant trial for myelodysplastic syndromes and myelopr…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bone marrow transplantation with cyclophosphamide and total-body irradiation in patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS) [Phase 3]
Extension study to continue azacitidine in patients with myelodysplastic syndromes after completion of the main AZA PH GL 2003 CL 001 trial.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 clinical trial evaluates total-body irradiation with cyclophosphamide and stem cell transplantation in patients with hematologic c…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial tested total-body irradiation with thiotepa and fludarabine as conditioning before donor stem cell transplant in …
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [NA]
A completed clinical trial update examining the emotional needs of caregivers of stem cell transplantation patients is reported.
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant [Phase 1]
Phase 1 clinical trial update on cellular adoptive immunotherapy for patients with acute myeloid leukemia, acute lymphoblastic leukemia, or …
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder [Phase 1, Phase 2]
Phase 1/2 clinical trial update on donor peripheral stem cell transplantation for patients with acute myeloid leukemia, myelodysplastic synd…
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes [Phase 2]
A Phase 2 clinical trial evaluating anti-thymocyte globulin and etanercept for myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia [Phase 3]
A Phase 3 trial evaluating daunorubicin and cytarabine with or without zosuquidar in older patients with newly diagnosed acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose busulfan and high-dose cyclophosphamide conditioning followed by donor bone marrow transplantation in p…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care [Phase 3]
A phase 3 trial comparing azacitidine to conventional care in high-risk myelodysplastic syndromes has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy in children with newly diagnosed acute myeloid leukemia or myelodysplastic syndro…